European Journal of Cancer Supplements
-
Publication Venue For
- 313 POSTER Pediatric preclinical testing program (PPTP) evaluation of the KSP inhibitor Ispinesib (SB-715992). 4:98-98. 2006
- 322 POSTER Pediatric Preclinical Testing Program (PPTP) evaluation of the Src-Abl inhibitor dasatinib (BMS-354825). 4:101-101. 2006
- E10. Interpreting the results of the women's health initiative within the context of our current understanding of oestrogen and progesterone action. 2:35-40. 2004
- Delivering optimal adjuvant chemotherapy in primary breast cancer: The role of rHuG-CSF. 1:1-12. 2003
- 39 Targeting the lactate transporter monocarboxylate transporter 1 constitutes a new therapeutic modality that disrupts a fundamental metabolic symbiosis in tumours 2010
- 7028 Dasatinib and docetaxel combination treatment for patients with metastatic castration-resistant prostate cancer (CRPC): analysis of Study CA180–086 2009
- 8707 Clinical assessment of corticosteroid use and neurocognitive function in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study 2009
- 8721 Evaluation of objective response as a predictor of survival in bevacizumab-treated patients with glioblastoma at first or second relapse in the BRAIN Study 2009
- 398 POSTER Phase I, pharmacokinetic (PK), dose-escalation study of EZN-2968, a novel hypoxia-inducible factor-1 alpha (HIF-1a) antagonist, administered weekly in patients (pts) with solid tumours 2008
- 558 POSTER Pediatric Preclinical Testing Program (PPTP) evaluation of the fully human anti-IGF-1R antibody IMC-A12 2008
- 2039 POSTER Radiotherapy after breast conserving surgery for ductal carcinoma in situ: an overview of randomized trials 2007
- 2071 POSTER High dose chemotherapy with marrow or stem cell transplantation versus conventional chemotherapy for breast cancer: an overview of randomized trials 2007
- 2084 POSTER Acute myeloid leukaemia and myelodysplastic syndrome after taxane-based adjuvant chemotherapy for early breast cancer: an exploratory meta-analysis 2007
- 6524 POSTER Primary tumour standardized uptake value (SUV max) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Staging Project 2007
- 6578 POSTER No evidence of an association between EGFR inhibitor treatment and interstitial lung disease in patients with advanced lung cancer 2007
- 127 POSTER Down-regulation of Sphingosine 1-Phosphate Receptor-1 in intestinal tumorigenesis 2006
- Randomized phase III trial of gemcitabine (GEM) versus pegylated liposomal doxorubicin (PLDOX) for patients (pts.) with platinum-resistant (pt-r) ovarian cancer (oc) undergoing second or third-line chemotherapy (ct) 2005